Y Intercept Hong Kong Ltd Makes New Investment in Azenta, Inc. (NASDAQ:AZTA)

Y Intercept Hong Kong Ltd acquired a new stake in Azenta, Inc. (NASDAQ:AZTA) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 21,610 shares of the company’s stock, valued at approximately $1,080,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Farther Finance Advisors LLC raised its position in Azenta by 20.0% in the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after purchasing an additional 256 shares in the last quarter. KBC Group NV grew its stake in shares of Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after purchasing an additional 698 shares during the period. Assenagon Asset Management S.A. acquired a new position in shares of Azenta in the 4th quarter worth approximately $200,000. Aigen Investment Management LP bought a new position in shares of Azenta during the 3rd quarter worth approximately $214,000. Finally, Empowered Funds LLC bought a new position in shares of Azenta during the 4th quarter worth approximately $293,000. 99.08% of the stock is owned by institutional investors.

Azenta Stock Performance

Shares of AZTA opened at $47.04 on Thursday. The company has a market cap of $2.15 billion, a price-to-earnings ratio of -15.79 and a beta of 1.47. The stock has a fifty day moving average price of $50.43 and a two-hundred day moving average price of $47.86. Azenta, Inc. has a 52-week low of $38.82 and a 52-week high of $67.77.

Azenta (NASDAQ:AZTA) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, research analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on AZTA shares. Evercore ISI upped their price target on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and issued a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Finally, Needham & Company LLC lifted their price target on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.